Introduction
Launching a veterinary product brand doesn’t have to start with building a manufacturing facility. Many businesses, from first-time entrepreneurs to established distributors, enter the animal healthcare market by working with a third party veterinary medicine manufacturer that produces their branded products under an existing licensed facility.
This guide explains what third-party veterinary medicine manufacturing actually involves, what to consider before entering an agreement, and where new entrants commonly get confused.
The Main Issue: Confusing Manufacturing With Simple Relabeling
Many first-time brand owners assume third-party manufacturing means buying bulk products and relabeling them. In practice, it’s a more structured arrangement: the brand owner selects from existing formulations or requests custom development, and the manufacturer handles production, quality testing, and packaging under its own licensed facility, with the client’s brand name and packaging on the final product.
This confusion often leads to unclear expectations, particularly around who is responsible for regulatory compliance, batch documentation, and quality assurance once the product reaches the market.
Key Considerations
- Manufacturing licence and certification: Confirm the manufacturer holds a valid state drug licence and, ideally, WHO-GMP or cGMP certification.
- Formulation flexibility: Some manufacturers offer only existing formulations; others support custom development.
- Minimum order quantities: MOQs vary by product category, such as injections, boluses, or feed supplements, and affect your initial investment.
- Documentation: Batch manufacturing records and test reports should be provided for every order.
- Packaging and branding support: Check whether design assistance is included or handled separately.
Practical Guidance
Before signing an agreement, request the manufacturer’s drug licence and GMP certificate directly rather than relying on website claims. Ask for sample batches with corresponding quality test reports to evaluate consistency firsthand.
Clarify MOQs, lead times, and payment terms in writing, and confirm who handles regulatory filings tied to your brand. If you’re new to the sector, starting with a smaller trial order across one or two product categories can help you evaluate reliability before committing to a full catalogue.
Common Mistakes to Avoid
- Not verifying the manufacturer’s drug licence and GMP status independently.
- Assuming every manufacturer supports custom formulations, when many only offer existing catalogues.
- Underestimating MOQs and their impact on upfront investment.
- Skipping a review of batch documentation before placing the first order.
- Leaving formulation ownership and IP terms undefined when custom products are involved.
When Professional Help May Be Useful
If you’re entering veterinary pharma for the first time, unfamiliar with drug licensing requirements, or planning a multi-product launch, consulting directly with an experienced manufacturer’s team early can help you avoid costly missteps.
This is particularly true for businesses developing new formulations, since regulatory documentation requirements can be detailed and vary depending on the product category and target market.
Conclusion
Third-party manufacturing offers a practical route into the veterinary pharma business without the capital investment of building a facility, but it works best when brand owners understand the process and ask the right questions upfront.
To explore this route, you can review third-party manufacturing services, browse the existing product list, or contact the team directly with your requirements.
Frequently Asked Questions
1. What does third-party veterinary medicine manufacturing mean?
It refers to an arrangement where a licensed manufacturer produces veterinary medicines — such as injections, boluses, or supplements — under a client’s own brand name and packaging, while the manufacturer handles production, testing, and regulatory compliance at their own facility.
2. How is third-party manufacturing different from a PCD franchise?
Third-party manufacturing focuses on producing your own branded products through an existing facility, while a PCD franchise typically involves distributing an established company’s existing products under monopoly rights in a specific territory, without manufacturing involvement.
3. What documents should I request before placing an order?
Ask for the manufacturer’s state drug manufacturing licence, WHO-GMP or cGMP certificate, and batch-wise quality test reports for the specific products you’re ordering, confirming the facility is legally authorised and products meet required standards.
4. What is a typical minimum order quantity for third-party veterinary manufacturing?
MOQs vary significantly by product type and manufacturer, with injections and boluses often requiring different minimum batch sizes than feed supplements. It’s best to confirm exact MOQs directly for each product category you’re considering.
5. Can I request a custom formulation through third-party manufacturing?
Many manufacturers offer this, though not all. Custom formulation typically requires additional documentation, testing, and lead time compared to ordering from an existing catalogue, so it’s worth clarifying this capability upfront.
6. Who is responsible for quality if something goes wrong with a product?
Responsibility is generally defined in the manufacturing agreement, depending on whether the issue relates to production quality or marketing and distribution. A clear written contract helps avoid disputes later.
7. Do I need my own drug licence to sell veterinary medicines under my brand?
This depends on your specific business activity and applicable state regulations. It’s advisable to confirm licensing requirements for your role directly with the relevant drug control authority before launching.
8. How long does it typically take to launch a product through third-party manufacturing?
Timelines vary based on whether you’re using an existing formulation or developing a custom one, along with packaging design and approval steps. Existing formulations are generally quicker to bring to market.
9. What product categories are commonly available through veterinary third-party manufacturing?
Common categories include antibiotic and anti-inflammatory injections, calcium and antibiotic boluses, feed supplements like liver tonics and mineral mixtures, and nutritional formulations for livestock, poultry, and companion animals.
10. Is WHO-GMP certification mandatory for veterinary medicine manufacturers in India?
WHO-GMP is a globally recognised quality certification rather than a blanket legal mandate for every category, though many states require GMP compliance for drug manufacturing licences. Choosing a WHO-GMP certified manufacturer is a strong indicator of consistent practices.
